|
N-hydroxy-4-[[(2R)-3-oxo-2-(thiophen-2-ylmethyl)-2,4-dihydroquinoxalin-1-yl]methyl]benzamide
|
N609412-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[2-(2-chlorophenyl)ethyl]-4-[[3-(2-methylphenyl)piperidin-1-yl]methyl]-N-pyrrolidin-3-ylbenzamide
|
N609409-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[2-(2-chlorophenyl)ethyl]-4-[[3-(2-methylphenyl)piperidin-1-yl]methyl]-N-pyrrolidin-3-ylbenzamide
|
N609409-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2-hydroxyethyl)-3-[2-[[3-(trifluoromethyl)phenyl]methyl]-1-benzofuran-4-yl]benzamide
|
N609406-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(2-hydroxyethyl)-3-[2-[[3-(trifluoromethyl)phenyl]methyl]-1-benzofuran-4-yl]benzamide
|
N609406-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(3-((4R,5R,6R)-2-Amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-2,3-dihydro-[1,4]dioxino[2,3-c]pyridine-7-carboxamide
|
N609393-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-(3-((4R,5R,6R)-2-Amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-2,3-dihydro-[1,4]dioxino[2,3-c]pyridine-7-carboxamide
|
N609393-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-cyclohexyl-3-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyanilino]-1-methylpyrazole-4-carboxamide
|
N609385-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-cyclohexyl-3-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyanilino]-1-methylpyrazole-4-carboxamide
|
N609385-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[(2S)-1-[4-(5-chloro-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]naphthalene-2-carboxamide
|
N609369-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[(2S)-1-[4-(5-chloro-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]naphthalene-2-carboxamide
|
N609369-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)sulfanyl]ethyl 2,4-dichlorobenzoate
|
N609356-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)sulfanyl]ethyl 2,4-dichlorobenzoate
|
N609356-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[(4,4-difluoro-1-hydroxycyclohexyl)methyl]-6-fluoro-4-oxochromene-2-carboxamide
|
N609354-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[(4,4-difluoro-1-hydroxycyclohexyl)methyl]-6-fluoro-4-oxochromene-2-carboxamide
|
N609354-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-{2-[(5-chloro-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}prop-2-enamide
|
N609352-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-{2-[(5-chloro-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}prop-2-enamide
|
N609352-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[[3-[4-fluoro-3-(trifluoromethyl)phenyl]-1,2-oxazol-5-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide
|
N609333-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[[3-[4-fluoro-3-(trifluoromethyl)phenyl]-1,2-oxazol-5-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide
|
N609333-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N4-(propan-2-yl)-N2-[3-(pyridin-3-yl)phenyl]pyrimidine-2,4-diamine
|
N609331-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N4-(propan-2-yl)-N2-[3-(pyridin-3-yl)phenyl]pyrimidine-2,4-diamine
|
N609331-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-({[7-(naphthalen-2-yl)-1-benzothiophen-2-yl]methyl}amino)butanoic acid
|
N609325-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-({[7-(naphthalen-2-yl)-1-benzothiophen-2-yl]methyl}amino)butanoic acid
|
N609325-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[3-[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]-1H-indol-5-yl]acetamide
|
N609320-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |